Representative before the EPO

Employment test 11 - 50 employees
Company dna forresters
operating since 1884
Headquarter in Birmingham and 5 offices
active in Legal Services and IP Consulting

Representative before the EPO

Company dna forrester and boehmert
operating 1977 - 2012
2 offices
active in Legal Services

We have observed 164 EP applications Jonathan Vallance Gowshall has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 16, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11850419

PHARMACEUTICAL FORMULATIONS CONTAINING CORTICOSTEROIDS FOR TOPICAL ADMINISTRATION

IPC classification:
A61K 31/56
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP11845227

METHOD FOR STIMULATING OSTEOGENESIS

IPC classification:
D04H 13/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12753030

PEPTIDE-LIPID CONSTRUCTS AND THEIR USE IN A FC-FUNCTION ASSAY

IPC classification:
C07F 9/10, C07K 14/00, C07K 14/045, C07K 17/06, G01N 33/53, G01N 33/531, G01N 33/536, G01N 33/555, G01N 33/68, A61K 31/683, A61K 38/16, A61K 39/385
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12759932

MICROBIAL PRODUCTION OF CHEMICAL PRODUCTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS

IPC classification:
C12P 1/00
Agent:
Multiple attorneys, Avidity IP Ltd
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12765325

GENE EXPRESSION PREDICTORS OF CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/50
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12768032

BIO-BASED BINDERS INCLUDING CARBOHYDRATES AND A PRE-REACTED PRODUCT OF AN ALCOHOL OR POLYOL AND A MONOMERIC OR POLYMERIC POLYCARBOXYLIC ACID

IPC classification:
C09D 103/02, D04H 13/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Cass A.C. Dottridge, Cargill Europe bvba
Status:
EXAMINATION IN PROGRESS
EP12717009

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
C07K 16/30
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12726986

ADIPOSE TISSUE MATRICES

IPC classification:
A61L 27/36, A61L 27/56, A61L 27/58
Applicant:
Lifecell Corporation
Agent:
Multiple attorneys, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12735414

P97-ANTIBODY CONJUGATES AND METHODS OF USE

IPC classification:
A61P 35/00, C12N 9/00, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12802203

SELF-RENEWING ENDODERMAL PROGENITOR LINES GENERATED FROM HUMAN PLURIPOTENT STEM CELLS AND METHODS OF USE THEREOF

IPC classification:
C12N 5/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12802232

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H1N1 INFLUENZA

IPC classification:
C12N 15/33, C12N 15/44, C12N 15/63
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP12741191

METHODS AND COMPOSITIONS FOR INHIBITING POLYOMAVIRUS-ASSOCIATED PATHOLOGY

IPC classification:
C07K 16/08
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12701626

METHODS FOR AMPLIFICATION AND DETECTION OF PRIONS

IPC classification:
G01N 33/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Meissner Bolte & Partnerschaft mbB
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Birgit Weber, Life Technologies GmbH
Status:
GRANT OF PATENT INTENDED
EP11848181

GLYCOSIDE BLENDS

IPC classification:
C07H 15/207
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Multiple attorneys, Cargill Europe bvba
Status:
EXAMINATION REQUESTED
EP12833937

METHODS AND COMPOSITIONS FOR EXPANDING CELLS AND IMPROVING ENGRAFTMENT

IPC classification:
C12N 5/071, C12N 5/074, C12N 15/63, G01N 33/50, A61L 27/38
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12746240

P97 FRAGMENTS WITH TRANSFER ACTIVITY

IPC classification:
C07K 14/79, A61K 38/40
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12782865

SYSTEMS AND METHODS FOR INDIVIDUALIZED FUNCTIONAL GENOMIC PROFILIING RELATED TO CANCER CELL GROWTH

IPC classification:
C12M 1/34, C12Q 1/68
Agent:
Pfenning Meinig & Partner GbR
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12761841

INFLUENZA VIRUSES WITH MUTANT PB2 GENE SEGMENT AS LIVE ATTENUATED VACCINES

IPC classification:
C12N 7/00, G01N 33/569, A61K 39/145
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12841840

IMPROVED METHOD AND APPARATUS FOR GROWING SPROUTS

IPC classification:
A01C 1/00, A01C 1/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12780376

N-DEMETHYASE GENES AND USES THEREOF

IPC classification:
C12N 1/19, C12N 1/21, C12N 9/00, C12N 15/53, C12P 17/18, C12Q 1/26
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14163233

Prediction of likelihood of cancer recurrence

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP12847964

METHOD OF PREDICTING BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/50
Agent:
Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12847241

NEUTRALIZING GP41 ANTIBODIES AND THEIR USE

IPC classification:
A61P 31/18, C07K 16/10, C12N 15/13, A61K 39/42
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12806795

COMPOSITIONS AND METHODS FOR ENHANCED GENERATION OF HEMATOPOIETIC STEM/PROGENITOR CELLS

IPC classification:
C12N 5/0789, A61K 35/12
Applicant:
Novartis AG
Applicant:
Fred Hutchinson Cancer Research Center
Applicant:
Novartis Institute for Functional Genomics, Inc.
Agent:
Jones Day
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12855597

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

IPC classification:
A61P 31/18, C07K 16/10, C12N 15/13, G01N 33/569, A61K 39/42
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12858324

CONTROL AND DELIVERY OF ELECTRIC FIELDS VIA AN ELECTRODE ARRAY

IPC classification:
A61B 18/18
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12880480

BIOCOMPATIBLE METHOD OF FUNCTIONALISING SUBSTRATES WITH INERT SURFACES

IPC classification:
G01N 33/48, G01N 33/53, G01N 33/543
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12849133

PROCESSES AND SYSTEMS FOR NON-EQUILIBRIUM TRICHLOROSILANE PRODUCTION

IPC classification:
B01J 6/00, B01J 23/26, B01J 23/755, C01B 33/107
Applicant:
SiTec GmbH
Agent:
Multiple attorneys, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14163244

Gene expression profiling in biopsied tumor tissues

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP13738804

TOPICAL THERAPEUTIC FORMULATIONS

IPC classification:
A61P 17/00, A61P 19/04, A61K 31/4422, A61K 35/12, A61K 38/44
Agent:
Pfenning Meinig & Partner GbR
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13744228

PROMOTING TRANSCRANIAL DIRECT CURRENT STIMULATION OR TRANSCRANIAL MAGNETIC STIMULATION USING TEMPERATURE-INDUCED SYNAPTIC MODULATION

IPC classification:
A61N 1/04, A61N 1/20, A61N 2/02
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13747212

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H3N2, H2N2, AND B INFLUENZA VIRUSES

IPC classification:
A61P 31/16, C07K 14/11, C12N 15/44, A61K 39/145
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13749680

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR HUMAN AND AVIAN H5N1 INFLUENZA

IPC classification:
A61P 31/16, C07K 14/11, C12N 15/44, C12N 15/63, A61K 39/145
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP12799947

TEM8 ANTIBODIES, CONJUGATES THEREOF, AND THEIR USE

IPC classification:
C07K 16/28, C07K 16/30
Applicant:
Novartis AG
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13713301

SOLUBLE ENGINEERED MONOMERIC FC

IPC classification:
C07K 16/00, C07K 16/10
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13763664

NEUTRALIZING ANTIBODIES TO HIV-1 AND THEIR USE

IPC classification:
A61P 31/18, C07K 16/10, A61K 39/42
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13769077

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H5N1 AND H1N1 INFLUENZA VIRUSES

IPC classification:
C07K 14/11, C12N 15/44, A61K 31/16, A61K 39/145
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13834351

COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER

IPC classification:
A61P 1/16, A61P 19/02, A61P 25/00, A61P 29/00, A61P 35/00, A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/235, A61K 31/7076, A61K 45/06, A61K 47/14
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11845757

METHODS FOR TREATING A TUMOR USING AN ANTIBODY THAT SPECIFICALLY BINDS GRP94

IPC classification:
C07K 16/18, C07K 16/30, A61K 31/437, A61K 35/00, A61K 39/00, A61K 39/395, A61K 45/06
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12881774

HIGHLY MULTIPLEX PCR METHODS AND COMPOSITIONS

IPC classification:
C12Q 1/68
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Multiple attorneys, Forresters IP LLP
Status:
PATENT GRANTED
EP14195969

Compositions and methods for treating diseases of the nail

IPC classification:
C07F 9/06, A61K 31/454, A61K 31/675, A61K 47/10, A61K 47/14, A61K 47/24
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13727753

METHODS OF REGULATING CANNABINOID RECEPTOR ACTIVITY-RELATED DISORDERS AND DISEASES

IPC classification:
A61P 35/00, A61K 31/05, A61K 45/06
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14185860

Impregnated odour control products and methods of making the same

IPC classification:
A63B 21/00, C08K 5/00, C12N 1/20, C12N 3/00, D01F 1/10, A01N 25/10, A01N 25/34, A01N 63/00, A43B 1/00, A43B 13/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14189399

Mutation in OAS1 genes

IPC classification:
C12N 9/12, C12Q 1/68, A61K 38/16
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13712625

METHODS AND COMPOSITIONS FOR DETECTION OF LEGIONELLA

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13713612

CAFFEINE RESPONSIVE PROMOTERS AND REGULATORY GENES

IPC classification:
C12N 15/63
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13806393

METHOD FOR OBTAINING FETAL CELLS AND FETAL CELLULAR COMPONENTS

IPC classification:
C12N 5/073, G01N 33/50, A61B 10/00, A61B 10/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13737939

TISSUE-BASED DRAIN MANIFOLDS

IPC classification:
A61L 31/04, A61M 27/00
Applicant:
Lifecell Corporation
Agent:
Multiple attorneys, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13745754

MACROPOROUS CATHETER

IPC classification:
A61B 5/00, A61B 5/145, A61B 10/00, A61L 29/00, A61M 1/28, A61M 25/00, A61M 27/00, A61M 31/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP11858061

METHODS FOR NON-INVASIVE PRENATAL PLOIDY CALLING

IPC classification:
C12Q 1/68, G01N 33/48, G06F 19/18, G06F 19/22
Agent:
Richard Gibbs, Marks & Clerk LLP
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13747600

DEPHOSPHORYLATED LYSOSOMAL STORAGE DISEASE PROTEINS AND METHODS OF USE THEREOF

IPC classification:
C12N 9/16, A61K 38/46, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13829596

METHODS AND COMPOSITIONS FOR REDUCING GENETIC LIBRARY CONTAMINATION

IPC classification:
C07H 21/04, C12P 19/34, C40B 30/04, C40B 40/06, C40B 40/08
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13753475

MESOTHELIN DOMAIN-SPECIFIC MONOCLONAL ANTIBODIES AND USE THEREOF

IPC classification:
C07K 16/30, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13835916

METHODS FOR INCREASING FETAL FRACTION IN MATERNAL BLOOD

IPC classification:
C40B 20/00
Agent:
Philip Michael Webber, Dehns Ltd
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14195468

Methods for non-invasive prenatal ploidy calling

IPC classification:
C12Q 1/68
Agent:
Multiple attorneys, Forresters IP LLP
Status:
PATENT GRANTED
EP13766859

MESOTHELIN ANTIBODIES AND METHODS FOR ELICITING POTENT ANTITUMOR ACTIVITY

IPC classification:
A61P 35/00, C07K 16/30, A61K 39/395
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP15158222

Edge coatings for adhesive tapes

IPC classification:
C09J 7/02, C09J 7/04
Agent:
Multiple attorneys, Forresters IP LLP
Agent:
Carrie-Anne Louise Johnson, Barker Brettell LLP
Status:
EXAMINATION REQUESTED
EP15152517

Method for using gene expression to determine prognosis of prostate cancer

IPC classification:
C12Q 1/68, G01N 33/574
Agent:
Multiple attorneys, Forresters IP LLP
Agent:
Williams Powell
Status:
PATENT GRANTED
EP15162282

Brachyury polypeptides and methods for use

IPC classification:
C07K 4/12, C07K 14/47, C07K 14/82, C12N 15/113, G01N 33/569, G01N 33/574, A61K 39/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP13855449

TREATMENT OF POST-TRAUMATIC STRESS DISORDER USING BOTULINUM TOXIN A

IPC classification:
A61K 39/08
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13855135

SURGICAL SYSTEM

IPC classification:
A61B 19/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13857490

INHIBITORS OF THE T CELL-SPECIFIC ALTERNATIVE P38 ACTIVATION PATHWAY AND METHODS OF USE

IPC classification:
A61P 37/00, C07K 7/08, C07K 19/00, A61K 38/10
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13859229

COMPUTATIONALLY OPTIMIZED BROADLY REACTIVE ANTIGENS FOR H1N1 INFLUENZA

IPC classification:
C07K 14/11, C12N 15/44, A61K 38/16, A61K 39/145
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13863944

ANTI-NTB-A ANTIBODIES AND RELATED COMPOSITIONS AND METHODS

IPC classification:
A61K 39/395
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14737656

COMPOSITIONS AND METHODS FOR DELIVERY OF IMMUNE CELLS TO TREAT UN-RESECTABLE OR NON-RESECTED TUMOR CELLS AND TUMOR RELAPSE

IPC classification:
C12N 5/0783
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14702339

COMPOSITIONS AND METHODS FOR EXPANSION OF EMBRYONIC HEMATOPOIETIC STEM CELLS

IPC classification:
C12N 5/0789, A61K 35/28
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jones Day
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14740896

ADENOVIRUSES AND THEIR USE

IPC classification:
A61P 31/20, C07K 14/075, C07K 16/08, C12N 5/10, C12N 15/34, C12N 15/63, C12N 15/861, C12P 21/02, C12Q 1/68, A61K 39/12
Applicant:
University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15173816

GENE EXPRESSION MARKERS FOR PREDICTING RESPONSE TO CHEMOTHERAPY

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP15162054

COMPOSITIONS COMPRISING S-ADENOSYLMETHIONINE AND A GALLIC ACID ESTER

IPC classification:
A61P 1/16, A61P 19/02, A61P 25/00, A61P 29/00, A61P 35/00, A61K 9/20, A61K 9/28, A61K 9/48, A61K 31/235, A61K 31/7076, A61K 45/06, A61K 47/14
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14706762

COMPOSITIONS AND METHODS FOR TREATING AND REPAIRING TENDONS

IPC classification:
C12N 5/077, C12N 5/0775, A61K 35/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14754421

METHODS OF SEQUENCING NUCLEIC ACIDS IN MIXTURES AND COMPOSITIONS RELATED THERETO

IPC classification:
C12N 15/10, C12Q 1/68
Applicant:
Johns Hopkins University
Applicant:
Emory University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15170077

DECELLULARIZATION AND RECELLULARIZATION OF ORGANS AND TISSUES

IPC classification:
C12M 1/12, C12M 1/26, C12M 3/00, C12N 5/071, A61K 9/00, A61K 35/12, A61K 35/34, A61M 1/10
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14716493

FRAGMENTS OF P97 AND USES THEREOF

IPC classification:
C07K 14/79
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14763713

ACTIVATED CARBON FILTRATION FOR PURIFICATION OF BENZODIAZEPINE ADCs

IPC classification:
B01D 15/04, C02F 1/28, C07D 243/12, A01N 43/62, A61K 31/55, A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14778142

CYCLODEXTRIN AND ANTIBODY-DRUG CONJUGATE FORMULATIONS

IPC classification:
C07D 487/00, C07K 16/00, A01N 43/04, A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14722428

HYPOSIALYLATION DISORDERS

IPC classification:
G01N 33/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
Emory University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14763831

ACETYL-COA CARBOXYLASE MUTATIONS

IPC classification:
C12N 1/21, C12N 9/00, C12N 15/52
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14768529

COMPOSITIONS AND METHODS TO MODIFY CELLS FOR THERAPEUTIC OBJECTIVES

IPC classification:
C12N 15/62
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14775224

PREFUSION RSV F PROTEINS AND THEIR USE

IPC classification:
A61P 43/00, C07K 14/135, C12N 15/45, C12N 15/62, A61K 38/10, A61K 39/00, A61K 39/155
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14783418

CHIMERIC ADENO-ASSOCIATED VIRUS/ BOCAVIRUS PARVOVIRUS VECTOR

IPC classification:
A61K 39/23
Applicant:
University of Iowa Research Foundation
Applicant:
University of Kansas
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Pfizer Inc
Status:
EXAMINATION REQUESTED
EP13881946

DEMOLITION SHEAR AND DEMOLITION SHEAR PIERCING TIP INSERT AND NOSE CONFIGURATION

IPC classification:
B23D 35/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14723540

DEVICES AND METHODS FOR TREATING FUNCTIONAL TRICUSPID VALVE REGURGITATION

IPC classification:
A61F 2/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14764077

STEVIA PLANTS WITH AN INCREASED REBAUDIOSIDE D CONTENT

IPC classification:
A01H 5/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14724976

LONE STAR VIRUS

IPC classification:
C07K 14/175, C07K 16/10, C12N 7/00, G01N 33/569
Applicant:
University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14794851

IN SITU MIXING AND APPLICATION OF HYDROCOLLOID SYSTEMS FOR PRE-AND POST HARVEST USE ON AGRICULTURAL CROPS

IPC classification:
A01N 25/00
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14727696

SINGLE-DOMAIN VHH ANTIBODIES DIRECTED TO NOROVIRUS GI.1 AND GII.4 AND THEIR USE

IPC classification:
A61P 31/12, A61P 31/14, C07K 16/08, C07K 16/10, G01N 33/569, A61K 39/395
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP15188264

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
C07K 16/28, C07K 16/30, G01N 33/574, G01N 33/68, A61K 39/00, A61K 39/395, A61K 47/48
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14798331

ADENO-ASSOCIATED VIRUS MEDIATED GENE TRANSFER TO THE CENTRAL NERVOUS SYSTEM

IPC classification:
C12N 15/00, C12N 15/86, A01N 63/00
Applicant:
Regents of the University of Minnesota
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14728395

COMPOUNDS FOR INHIBITING DRUG-RESISTANT STRAINS OF HIV-1 INTEGRASE

IPC classification:
C07D 471/04, A61K 31/4375, A61K 31/4704, A61K 31/496, A61K 31/5377, A61K 45/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14803477

CONOTOXIN PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

IPC classification:
A61K 38/10
Applicant:
University of Utah Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15195219

METHODS FOR PREPARING COMPLEX MULTIVALENT IMMUNOGENIC CONJUGATES

IPC classification:
A61K 39/00, A61K 39/08, A61K 39/095, A61K 39/385, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14735030

ENCIRCLING IMPLANT DELIVERY SYSTEMS AND METHODS

IPC classification:
A61F 2/24
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP15199388

SYSTEM AND METHOD FOR CLEANING NOISY GENETIC DATA AND USING DATA TO MAKE PREDICTIONS

IPC classification:
G06F 19/18, G06F 19/22, G06F 19/24
Agent:
Richard Gibbs, Marks & Clerk LLP
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14737128

COMPOSITIONS AND METHODS FOR TREATING SKIN

IPC classification:
A61P 17/00, C12N 5/071, A61K 35/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14817352

DEVICES, SYSTEMS AND METHODS FOR MONITORING KNEE REPLACEMENTS

IPC classification:
A61B 5/103, A61B 17/56, A61F 2/38, A61F 2/46, A61F 2/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14745037

PHOTOACTIVATABLE LIPID-BASED NANOPARTICLES AS VEHICLES FOR DUAL AGENT DELIVERY

IPC classification:
A61P 35/00, A61K 41/00, A61K 47/48
Applicant:
Baylor College of Medicine
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP12755058

IN VIVO METHODS OF MONITORING BIODISTRIBUTION

IPC classification:
C07F 9/09, C07F 9/10, A61K 51/04, A61K 51/06, A61K 51/08
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14745060

HIGH TITER RECOMBINANT INFLUENZA VIRUSES WITH ENHANCED REPLICATION IN MDCK OR VERO CELLS OR EGGS

IPC classification:
C12N 7/00
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13812266

TRANSVASCULAR AND TRANSCAMERAL DEVICE ACCESS AND CLOSURE

IPC classification:
A61B 17/00, A61B 17/12
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14835867

SWEETENER AND SWEETENED COMPOSITIONS INCORPORATING REBAUDOSIDE N

IPC classification:
C07H 15/24, C13K 13/00, A23L 27/30, A23L 2/60
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Myriam Elseviers, Cargill Europe bvba
Status:
GRANT OF PATENT INTENDED
EP15191753

HUMAN FACILITATING CELLS AND USES THEREOF

IPC classification:
A61P 37/00, C12N 5/071, C12N 5/0789, A61K 35/12
Applicant:
University of Louisville Research Foundation, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14845828

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS

IPC classification:
C07C 233/07, C07C 233/11, C07C 235/34, C07C 237/20, C07C 255/00, C07C 271/28, C07C 275/28, C07C 307/10, C07C 311/03, C07D 209/18, C07D 213/74, C07D 215/02, C07D 231/56, C07D 235/04, C07D 249/18, C07D 263/54, C07D 277/62, A61K 31/165, A61K 31/17, A61K 31/18
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP14845373

COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION AND/OR FIBROSIS

IPC classification:
A61P 9/12, A61P 13/12, C07C 233/11, A61K 31/165
Agent:
Multiple attorneys, Forresters IP LLP
Status:
The patent has been granted
EP15202562

BRASSICA PLANTS YIELDING OILS WITH A LOW TOTAL SATURATED FATTY ACID CONTENT

IPC classification:
A01H 1/00, A01H 5/10
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP14790440

DETECTION OF HEPATITIS DELTA VIRUS (HDV) FOR THE DIAGNOSIS AND TREATMENT OF SJÖGREN'S SYNDROME AND LYMPHOMA

IPC classification:
C12Q 1/68, C12Q 1/70
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION IN PROGRESS
EP14854262

VASCULAR DILATORS

IPC classification:
A61M 25/01, A61M 25/04, A61M 29/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
GRANT OF PATENT INTENDED
EP13165713

Trimeric OX40-immunoglobulin fusion protein and methods of use

IPC classification:
C07K 14/52, C12P 21/02, A61K 39/39, A61K 45/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
PATENT GRANTED
EP14855615

METHODS OF DETERMINING BREAST CANCER PROGNOSIS

IPC classification:
C12Q 1/68, G01N 33/53
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14858957

METHODS OF INCORPORATION OF TRANSCRIPT CHROMOSOMAL LOCUS INFORMATION FOR IDENTIFICATION OF BIOMARKERS OF DISEASE RECURRENCE RISK

IPC classification:
G06F 19/26
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14855406

ATRIAL APPENDAGE LIGATION

IPC classification:
A61B 17/08, A61B 17/10, A61B 17/12, A61B 17/128, A61M 25/01
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16166924

HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR GLYPICAN-3 AND USE THEREOF

IPC classification:
C07K 16/28, C07K 16/30, G01N 33/574, G01N 33/68, A61K 39/00, A61K 39/395, A61K 47/48
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The patent has been granted
EP14803025

TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN

IPC classification:
A61P 25/00, A61K 31/00, A61K 38/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14863286

ALLELES MODIFYING BRASSICA PLANT TOTAL SATURATED FATTY ACID CONTENT

IPC classification:
G01N 33/48, G01N 33/50, A01H 5/00
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14812375

ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE

IPC classification:
C12N 9/16, C12N 15/86, A61K 48/00
Applicant:
University of Florida Research Foundation
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14863650

PREPARING ANTIBODIES FROM CHO CELL CULTURES FOR CONJUGATION

IPC classification:
C07K 1/14, A61K 39/395, A61K 47/48
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14831120

MULTI-EPITOPE TARP PEPTIDE VACCINE AND USES THEREOF

IPC classification:
A61K 39/00
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14871434

METHYLENE CARBAMATE LINKERS FOR USE WITH TARGETED-DRUG CONJUGATES

IPC classification:
A61K 47/48
Applicant:
Seattle Genetics, Inc.
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16166020

P97-ANTIBODY CONJUGATES

IPC classification:
A61P 35/00, C07K 14/79, C07K 16/32, C12N 9/00, C12N 9/14, A61K 45/06, A61K 47/48
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP14800182

SMALL MOLECULE IMAGING OF FUNGI BY POSITRON EMISSION TOMOGRAPHY SCANNING

IPC classification:
C07D 251/68, A61K 51/04
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
State University of New York University at Buffalo - Office Of Science Technology Transfer
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16157419

ANALOGS OF SHK TOXIN AND THEIR USES IN SELECTIVE INHIBITION OF KV1.3 POTASSIUM CHANNELS

IPC classification:
A61K 38/00
Applicant:
University of California
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP16162911

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION

IPC classification:
A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797, A61K 35/14, A61K 35/44, A61K 35/50
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
APPLICATION PUBLISHED
EP16166225

COMPOSITIONS AND METHODS FOR PROVIDING HEMATOPOIETIC FUNCTION WITHOUT HLA MATCHING

IPC classification:
A61P 7/00, A61P 35/02, C07K 16/28, C12N 5/0797, A61K 35/14, A61K 35/44, A61K 35/50
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16176482

METHOD FOR STERILISING DERMIS

IPC classification:
A61K 35/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15748980

HYDROPHILIC ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 38/08
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15708639

HIV-2 NUCLEIC ACIDS AND METHODS OF DETECTION

IPC classification:
C07K 14/16, C12Q 1/70
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16181799

GENE EXPRESSION PROFILING IN BIOPSIED TUMOR TISSUES

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15758457

EASILY DISPERSIBLE FORMULATIONS OF PIGMENTS AND THEIR USE IN TINTING BASE MEDIA

IPC classification:
C09B 67/00, C09C 3/08, C09C 3/10, C09D 5/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15762002

MULTIPLE PANEL SUTURE DISPENSING CARD AND METHOD FOR USING THE SAME

IPC classification:
A61B 17/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15712513

SYSTEM WITH AN ELECTROMAGNETIC FIELD GENERATOR WITH COILS FOR TREATING TUMORS AND A METHOD FOR TREATING TISSUE

IPC classification:
A61N 1/40, A61N 2/02
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15775944

OPTIMAL DOSING OF A CD19-ANTIBODY DRUG CONJUGATE

IPC classification:
C07K 16/28, A61K 39/395, A61K 47/42
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15776984

STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

IPC classification:
A61K 39/00
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15792704

HIGHLY SOLUBLE STEVIOL GLYCOSIDES

IPC classification:
A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Dela Kiadi Matsuela, Cargill Europe bvba
Status:
EXAMINATION REQUESTED
EP16187573

ANTIBODIES TO ENDOPLASMIN AND THEIR USE

IPC classification:
C07K 16/18, C07K 16/30, C12N 15/13, C12N 15/63, G01N 33/574, G01N 33/577, A61K 39/00, A61K 39/395
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16195347

METHOD FOR USING GENE EXPRESSION TO DETERMINE PROGNOSIS OF PROSTATE CANCER

IPC classification:
C12Q 1/68, G01N 33/574
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15729698

EXPANSION AND ENGRAFTMENT OF STEM CELLS USING NOTCH 1 AND/OR NOTCH 2 AGONISTS

IPC classification:
C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15747597

BLOCKING CD38 USING ANTI-CD38 F(AB')2 TO PROTECT NK CELLS

IPC classification:
A61P 35/00, A61P 37/00, C07K 16/28, A61K 39/395
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15727783

LILRB2 AND NOTCH-MEDIATED EXPANSION OF HEMATOPOIETIC PRECURSOR CELLS

IPC classification:
C12N 5/0789
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15812631

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING IMPLANTS

IPC classification:
A61F 2/12
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15811456

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING HEART VALVES

IPC classification:
A61F 2/24
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15745058

AEROSOL PARTICLE GROWTH SYSTEMS USING POLYMER ELECTROLYTE MEMBRANES

IPC classification:
G01N 15/06
Applicant:
Regents of the University of Minnesota
Agent:
Multiple attorneys, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP16196459

PREDICTION OF LIKELIHOOD OF CANCER RECURRENCE

IPC classification:
C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15829509

INJECTION DEVICES

IPC classification:
A61M 5/315
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
EXAMINATION REQUESTED
EP15839012

BOTULINUM TOXIN AND COLLOIDAL SILVER PARTICLES

IPC classification:
A61K 8/06, A61K 9/19, A61K 33/38, A61K 47/02
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15766697

RECOMBINANT HIV-1 ENVELOPE PROTEINS AND THEIR USE

IPC classification:
C07K 14/16, C12N 5/10, C12N 15/49, A61K 39/21
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15839347

TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCES

IPC classification:
C07K 7/02, A61K 45/06
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15842678

DEVICES, SYSTEMS AND METHODS FOR USING AND MONITORING MEDICAL DEVICES

IPC classification:
G06F 15/173
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16201265

TISSUE SCAFFOLDS

IPC classification:
A61L 27/36
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP15849315

METHODS AND COMPOSITIONS FOR INCREASING THE POTENCY OF ANTIFUNGAL AGENTS

IPC classification:
A61P 31/10, C07C 33/22
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15787824

SEGMENTED METALLIC GUIDEWIRES

IPC classification:
A61M 25/09
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15790793

DETECTION OF HIV-1 NUCLEIC ACIDS BY REVERSE-TRANSCRIPTION LOOP-MEDIATED ISOTHERMAL AMPLICATION

IPC classification:
C12Q 1/70
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15856774

USE OF D-RIBOSE TO ENHANCE ADAPTATION TO PHYSICAL STRESS

IPC classification:
A23L 2/38, A23L 2/52, A61K 31/7004
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15798305

TREATMENT OF HORMONAL DISORDERS OF GROWTH

IPC classification:
A61P 5/06, C07K 14/705
Applicant:
Université de Liège
Applicant:
Centre Hospitalier Universitaire de Liège
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15798623

TOPICAL SODIUM NITRITE FORMULATION

IPC classification:
A61K 9/00, A61K 9/06, A61K 33/00, A61K 47/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17162132

VALPROATE AS A TOPICAL ANTI-FUNGAL TREATMENT

IPC classification:
A61P 31/10, A61K 31/19
Applicant:
Wayne State University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP15871082

STEVIOL GLYCOSIDE COMPOUNDS, COMPOSITIONS FOR ORAL INGESTION OR USE, AND METHOD FOR ENHANCING STEVIOL GLYCOSIDE SOLUBILITY

IPC classification:
C07H 15/256, A23L 27/30
Applicant:
Cargill Inc
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Agent:
Dela Kiadi Matsuela, Cargill Europe bvba
Status:
Request for examination was made
EP15831073

RECOMBINANT METAPNEUMOVIRUS F PROTEINS AND THEIR USE

IPC classification:
C07K 14/005, C07K 14/115, C07K 14/135, C12N 15/09, A61K 39/155, A61K 39/39, A61K 48/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP15830932

ADENO-ASSOCIATED VIRUS VECTORS ENCODING MODIFIED G6PC AND USES THEREOF

IPC classification:
C12N 9/00, A61K 38/00
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17175325

B-CELL ANTIGEN PRESENTING CELL ASSAY

IPC classification:
G01N 33/68
Applicant:
University of Pittsburgh of the Commonwealth System of Higher Education
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP16738004

METHODS TO PREVENT OR TREAT PERIODONTITIS OR PERI-IMPLANTITIS

IPC classification:
C12N 5/00, C12N 15/11
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16740786

POINT-OF-CARE AND/OR PORTABLE PLATFORM FOR GENE THERAPY

IPC classification:
C12N 15/63, C12N 15/85, C12Q 1/68
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16703375

METHODS FOR THE REGENERATION OF ARTICULAR CARTILAGE IN VIVO

IPC classification:
A61P 19/00, A61P 19/02, A61K 38/18, A61K 38/19, A61K 38/20, A61K 38/39
Applicant:
University of Iowa Research Foundation
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP16749948

COMBINATION THERAPY USING A CD19-ADC AND VINCRISTINE

IPC classification:
A61P 35/02, C07K 16/28, A61K 39/395
Applicant:
Seattle Genetics, Inc.
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made
EP17183578

METHODS FOR PRODUCING AN IMMUNE RESPONSE TO TUBERCULOSIS

IPC classification:
A61P 31/06, C12N 15/86, C12N 15/867, G01N 33/569, A61K 9/00, A61K 38/00, A61K 38/16, A61K 39/00, A61K 39/04, A61K 39/385, A61K 39/39, A61K 49/00
Applicant:
Oregon Health & Science University
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
The application has been published
EP16714599

SIALYLATION-INCREASING THERAPIES FOR DISEASES ASSOCIATED WITH OXIDATIVE STRESS

IPC classification:
A61P 9/00, A61P 9/10, A61P 21/00, A61K 31/7012, A61K 31/702, A61K 31/7088, A61K 45/06
Agent:
Jonathan Vallance Gowshall, Forresters IP LLP
Status:
Request for examination was made

Please Sign in to use this feature